Martin Neuenschwander

8PUBLICATIONS
51CO-AUTHORS
Gene and molecular therapyCheminformatics and quantitative structure-activity relationshipsPharmacogenomicsProteins and peptidesPowder and particle technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 27, 2026
Drug Delivery Vehicle-Teriflunomide Interactions Affect Treatment and Fluorine Magnetic Resonance in an Animal Model of Multiple Sclerosis.

|Jul 11, 2026
Discovery and characterization of a novel class of cyclic peptidic compounds inhibiting the subunit interaction of the protein kinase CK2α2β2 holoenzyme.

|Jun 02, 2025
Inhibition of the Clathrin Terminal Domain-Amphiphysin Protein-Protein Interaction. Probing the Pitstop 2 Aromatic Moiety.

Kate Prichard, Mark J Robertson, Ngoc Chau

|Oct 16, 2023
An unconventional gatekeeper mutation sensitizes inositol hexakisphosphate kinases to an allosteric inhibitor.

Tim Aguirre, Gillian L Dornan, Sarah Hostachy

|Nov 11, 2022
Glycolytic flux control by drugging phosphoglycolate phosphatase.

Elisabeth Jeanclos, Jan Schlötzer, Kerstin Hadamek

|Sep 15, 2022
Development of selective inhibitors of phosphatidylinositol 3-kinase C2α.

Wen-Ting Lo, Hassane Belabed, Murat Kücükdisli

Pageof 2

Frequent Collaborators

4 joint publications

Marc Nazaré

3 joint publications

Volker Haucke

2 joint publications

André Horatscheck

1 joint publications

Christian Fetzer